Show results for
Refine by
Pancreatic Insulin Equipment & Supplies
6 equipment items found
by:Accelerated Biosciences Corp. based inCarlsbad, CALIFORNIA (USA)
We successfully isolated the hTSC from the chorionic villi of unruptured ectopic pregnancies. The chorionic villi develop from the trophectoderm of the embryo, which later becomes the placenta. hTSC’s pre-placental origin mitigates any ethical dilemmas involving the destruction of potential human ...
by:Accelerated Biosciences Corp. based inCarlsbad, CALIFORNIA (USA)
Stem cells possess two defining characteristics that give potential to address unmet medical needs in healthcare: 1) the ability to self-replicate throughout the life of an organism and 2) the ability to differentiate to many different cell types in the human ...
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
Significant advances in recent years mean that cell therapy is becoming a clinical reality. The unique characteristics of electrospun materials, including scaleability, minimal immunogenicity, regulatory familiarity and the ability to create a custom product, mean that they are well suited for this exciting area of regenerative medicine. We are confident that current challenges for the next ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Alogliptin Benzoate (SYR-322) is a potent, selective and orally active inhibitor of DPP-4 with an IC50 of <10 nM, and exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9. Alogliptin Benzoate can be used for the research of type 2 ...
by:Kadimastem Ltd. based inNes-Ziona, ISRAEL
We Have Reached Successful Pre-clinical results of our cell Therapy Treatment for Insulin-Dependent Diabetes. Diabetes mellitus is a chronic disorder characterized by high blood glucose levels and glucose intolerance, due to insulin deficiency, impaired effectiveness of insulin action, or both. Diabetes is classified on the basis of cause and ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
BRD3308 is 23-fold selectivity for HDAC3 over HDAC1 (IC50 of 1.26 μM) or HDAC2 (IC50 of 1.34 μM). BRD3308 suppresses pancreatic β-cell apoptosis induced by inflammatory cytokines or glucolipotoxic stress, and increases functional insulin release. BRD3308 activates HIV-1 transcription and disrupts HIV-1 ...